HCPCS Level II · Drugs administered other than oral method
J7401Mometasone furoate sinus implant, 10 micrograms
Terminated 03/31/2021
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J7401
J7401 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing mometasone furoate sinus implant, 10 micrograms.
It was added to HCPCS effective 10/01/2019, and its current record took effect 04/01/2021.
It was terminated on 03/31/2021 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Mometasone furoate sinus imp
- Date added
- 10/01/2019
- Action effective
- 04/01/2021
- Termination date
- 03/31/2021
- BETOS
- O1E
Related J74xx codes
Common questions about J7401
Is HCPCS J7401 still valid?
- No. J7401 was terminated on 03/31/2021.
Does Medicare cover J7401?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.